This multi-target strategy may explain why, in this case, only one anti-VEGF injection was needed to control macular edema, while patients receiving standard Western medicine treatment typically require four injections to achieve the same level of edema control effect (25). This evidence concerns the gene VEGFA and macular retinal edema.